Deborah Dillon

8.9k total citations · 1 hit paper
87 papers, 3.7k citations indexed

About

Deborah Dillon is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Deborah Dillon has authored 87 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 34 papers in Cancer Research and 21 papers in Molecular Biology. Recurrent topics in Deborah Dillon's work include Cancer Genomics and Diagnostics (22 papers), Breast Cancer Treatment Studies (15 papers) and HER2/EGFR in Cancer Research (13 papers). Deborah Dillon is often cited by papers focused on Cancer Genomics and Diagnostics (22 papers), Breast Cancer Treatment Studies (15 papers) and HER2/EGFR in Cancer Research (13 papers). Deborah Dillon collaborates with scholars based in United States, Brazil and Italy. Deborah Dillon's co-authors include Lili Ji, Kathleen A. Curtis, David L. Rimm, Eric R. Fearon, José Costa, Andrea L. Richardson, Eric P. Winer, Eric B. Rimm, Thomas G. D'Aquila and Rola A.D. Ghoussoub and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Deborah Dillon

85 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer

2022 163 citations Johann S. Bergholz, Sheheryar Kabraji et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Dillon United States	32	1.5k	1.5k	829	553	473	87	3.7k
Takayuki Ueno Japan	33	1.7k 1.1×	1.4k 0.9×	996 1.2×	311 0.6×	671 1.4×	186	3.9k
Steffen Hauptmann Germany	42	1.4k 0.9×	2.1k 1.5×	1.0k 1.2×	339 0.6×	634 1.3×	111	4.9k
Denise C. Connolly United States	35	1.5k 1.0×	2.0k 1.4×	736 0.9×	325 0.6×	353 0.7×	97	4.5k
Martin K. Oehler Australia	40	1.0k 0.7×	2.2k 1.5×	737 0.9×	193 0.3×	303 0.6×	164	4.5k
Elena Ioana Braicu Germany	40	1.7k 1.1×	2.1k 1.4×	1.2k 1.4×	300 0.5×	556 1.2×	303	5.4k
Matthias P. Ebert Germany	39	1.9k 1.2×	2.3k 1.6×	847 1.0×	421 0.8×	871 1.8×	161	5.1k
Ate G.J. van der Zee Netherlands	35	1.0k 0.7×	1.5k 1.1×	738 0.9×	647 1.2×	247 0.5×	63	3.8k
Jessica Wang‐Rodriguez United States	34	959 0.6×	2.0k 1.4×	894 1.1×	275 0.5×	634 1.3×	96	3.9k
Edward Gabrielson United States	31	1.0k 0.7×	1.6k 1.1×	1.0k 1.2×	256 0.5×	965 2.0×	59	3.4k
Phyu P. Aung United States	33	1.8k 1.1×	1.5k 1.0×	469 0.6×	554 1.0×	547 1.2×	188	4.0k

Countries citing papers authored by Deborah Dillon

Since Specialization

Citations

This map shows the geographic impact of Deborah Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dillon more than expected).

Fields of papers citing papers by Deborah Dillon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dillon. The network helps show where Deborah Dillon may publish in the future.

Co-authorship network of co-authors of Deborah Dillon

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Dillon. A scholar is included among the top collaborators of Deborah Dillon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Dillon. Deborah Dillon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Corti, Chiara, Xun Chu, Pedro Exman, et al.. (2025). Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative breast cancer: a single-center prospective observational study. ESMO Open. 10(8). 105521–105521.

Cho, Nam Woo, Barzin Y. Nabet, Kamir J. Hiam-Galvez, et al.. (2024). T Cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL1 and TNFα Inflammation. Cancer Immunology Research. 13(2). 229–244. 6 indexed citations

Silvestri, F, Michael Oliphant, Dennis P. Orgill, et al.. (2024). Breast organoid suspension cultures maintain long-term estrogen receptor expression and responsiveness. npj Breast Cancer. 10(1). 107–107. 3 indexed citations

Hughes, Melissa E., Alyssa R. Martin, Janet Files, et al.. (2024). Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survival. Neuro-Oncology. 27(1). 184–194. 4 indexed citations

Xia, Daniel, Frank C. Kuo, Melissa E. Hughes, et al.. (2023). HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer. American Journal of Clinical Pathology. 161(5). 436–442. 5 indexed citations

Gibson, Christopher J., Geoffrey Fell, Tal Sella, et al.. (2023). Clonal Hematopoiesis in Young Women Treated for Breast Cancer. Clinical Cancer Research. 29(13). 2551–2558. 15 indexed citations

Gupta, Hersh, Rachel A. Freedman, Melissa E. Hughes, et al.. (2023). Abstract P5-14-06: Tumor Genomic Landscape in Older Women with Metastatic Breast Cancer (MBC). Cancer Research. 83(5_Supplement). P5–14.

Gaglia, Giorgio, Sheheryar Kabraji, Yang Dai, et al.. (2022). Temporal and spatial topography of cell proliferation in cancer. Nature Cell Biology. 24(3). 316–326. 31 indexed citations

Basu, Sankha S., Sylwia A. Stopka, Walid M. Abdelmoula, et al.. (2021). Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery. npj Breast Cancer. 7(1). 116–116. 18 indexed citations

10.

Harrison, Beth, Faina Nakhlis, Deborah Dillon, et al.. (2020). Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations. Modern Pathology. 33(7). 1287–1297. 21 indexed citations

11.

Tolaney, Sara M., Romualdo Barroso‐Sousa, Tanya E. Keenan, et al.. (2020). Effect of Eribulin With or Without Pembrolizumab on Progression-Free Survival for Patients With Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast Cancer. JAMA Oncology. 6(10). 1598–1598. 110 indexed citations

12.

Bagati, Archis, Sushil Kumar, Peng Jiang, et al.. (2020). Integrin αvβ6–TGFβ–SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer. Cancer Cell. 39(1). 54–67.e9. 136 indexed citations

13.

Zoeller, Jason J., Krishan Taneja, Benjamin Y. Tan, et al.. (2019). Neutralization of BCL-2/XL Enhances the Cytotoxicity of T-DM1 In Vivo. Molecular Cancer Therapeutics. 18(6). 1115–1126. 25 indexed citations

14.

Fitzgibbons, Patrick L., Deborah Dillon, Randa Alsabeh, et al.. (2013). Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Breast. Archives of Pathology & Laboratory Medicine. 138(5). 595–601. 122 indexed citations

15.

White, Colin D., Zhigang Li, Deborah Dillon, & David B. Sacks. (2011). IQGAP1 Protein Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance. Journal of Biological Chemistry. 286(34). 29734–29747. 38 indexed citations

16.

Miron, Alexander, Mária Váradi, Daniel R. Carrasco, et al.. (2010). PIK3CA Mutations in In situ and Invasive Breast Carcinomas. Cancer Research. 70(14). 5674–5678. 107 indexed citations

17.

Leamon, John H., Tanja Pejović, Stefan Hamann, et al.. (2003). Whole Genome Analysis of Genetic Alterations in Small DNA Samples Using Hyperbranched Strand Displacement Amplification and Array–CGH. Genome Research. 13(2). 294–307. 212 indexed citations

18.

Dillon, Deborah, et al.. (2003). Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women. Cancer. 97(6). 1393–1403. 43 indexed citations

19.

Fusco, Alfredo, Gennaro Chiappetta, Pei Hui, et al.. (2002). Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma. American Journal Of Pathology. 160(6). 2157–2167. 110 indexed citations

20.

Dillon, Deborah, et al.. (2001). Rapid, Efficient Genotyping of Clinical Tumor Samples by Laser-Capture Microdissection/PCR/SSCP. Experimental and Molecular Pathology. 70(3). 195–200. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact